AKESOgen Revenue and Competitors

Claim your profile

Atlanta, GA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AKESOgen's estimated annual revenue is currently $3.4M per year.(i)
  • AKESOgen's estimated revenue per employee is $155,000

Employee Data

  • AKESOgen has 22 Employees.(i)
  • AKESOgen grew their employee count by -58% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2M13-13%N/AN/A
#2
$14.7M9514%$0.07BN/A
#3
$1.7M2713%N/AN/A
#4
$3.3M516%N/AN/A
#5
$9.6M62-11%N/AN/A
#6
$287.3M1464-20%$101.3MN/A
#7
$19.1M12348%$20.3MN/A
#8
$1.6M268%N/AN/A
#9
$37.8M19520%$14.2MN/A
#10
$3.8M6011%N/AN/A

AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

-58%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AKESOgen News

2022-03-22 - MDisrupt Lands $6 Million in Seed Funding to Build Its Digital ...

Investors include Bren Investments, Matthew Holt, Chantell Preston, Grail co-founder Jessica Owens, and AKESOgen co-founders Mark Bouzyk and...

2019-02-18 - RenalytixAI signs agreement for lab services

“AKESOgen brings a state-of-the-art CLIA-certified and CAP-accredited laboratory facility that enables RenalytixAI to immediately scale ...

2019-02-13 - Renalytix AI Partners With AKESOgen To Expand Pharma ...

LONDON (Alliance News) - Renalytix AI PLC on Wednesday said it has entered into a partnership agreement with laboratory facility provider ...

2019-02-13 - RenalytixAI and AKESOgen In Joint Venture Partnership for ...

NEW YORK, Feb. 13, 2019 /PRNewswire/ -- RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23N/AN/A
#2
$2.6M259%N/A
#3
$5M25-7%N/A
#4
$4.5M25-7%N/A
#5
$2.5M25N/AN/A